Lataa...
Omalizumab for Severe Asthma: Beyond Allergic Asthma
Different subsets of asthma patients may be recognized according to the exposure trigger and the frequency and severity of clinical signs and symptoms. Regarding the exposure trigger, generally asthma can be classified as allergic (or atopic) and nonallergic (or nonatopic). Allergic and nonallergic...
Tallennettuna:
| Julkaisussa: | Biomed Res Int |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166383/ https://ncbi.nlm.nih.gov/pubmed/30310816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/3254094 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|